| Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More | Frank Vinluan | 06/19/20 | National |
| FDA Staff Hammers Karyopharm Cancer Drug on Safety, Efficacy Concerns | Frank Vinluan | 02/22/19 | Boston |
| BCMA Day: At ASH ‘18, Cell Therapies For Myeloma Take Center Stage | Ben Fidler | 12/04/18 | National |
| Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More | Ben Fidler | 02/09/18 | National |
| Ocular Therapeutix Hit by Subpoena, SEC Seeks Eye Pain Drug Documents | Frank Vinluan | 12/22/17 | Boston |
| Otonomy Scraps Hearing Loss Drug After Phase 3 Flop, Shares Routed | Ben Fidler | 08/30/17 | San Diego |
| Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer | Ben Fidler | 08/16/17 | New York |
| Mattessich Starts as New Ocular CEO, Trims Staff in Cost-Saving Move | Frank Vinluan | 08/02/17 | Boston |
| FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths | Frank Vinluan | 07/05/17 | New York |
| In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths | Ben Fidler | 06/12/17 | New York |
| Silatronix, Propeller, BrainXell, & More: This Week’s WI Watchlist | Jeff Buchanan | 11/08/16 | Wisconsin |
| Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out | Ben Fidler | 08/08/16 | Boston |
| Ocular’s Shares Fall After Eye Treatment Fails Latest Test | Ben Fidler | 06/06/16 | Boston |
| Shire Snaps up New York’s Foresight Bio in $300M Pink Eye Deal | Ben Fidler | 08/03/15 | New York |
| East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More | Ben Fidler | 04/13/15 | Boston |
| East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More | Ben Fidler | 03/16/15 | Boston |
| Ocular’s Long-Lasting Eye Drug Tech Passes First Late-Stage Test | Ben Fidler | 03/10/15 | Boston |
| East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More | Ben Fidler | 02/20/15 | Boston |
| Tesaro Climbs on Phase 3 Data for Nausea Drug | Ben Fidler | 05/12/14 | Boston |
| Otonomy Raises $49M to Advance 3 Drugs for Treating Ear Diseases | Bruce V. Bigelow | 04/30/14 | San Diego |
| Otonomy Drug Could Have Broader Potential Application for Hearing Loss | Bruce V. Bigelow | 02/22/11 | San Diego |
